Canada markets closed

NLS Pharmaceutics Ltd. (NLSP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.1327+0.0002 (+0.15%)
At close: 04:00PM EDT
0.1378 +0.01 (+3.84%)
After hours: 05:29PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
7,816
8,977
5,919
99.58
Selling General and Administrative
6,528
6,506
5,941
2,200
Total Operating Expenses
14,344
15,482
11,861
2,299
Operating Income or Loss
-14,344
-15,482
-11,861
-2,299
Interest Expense
91.815
100.866
68.134
233.7
Total Other Income/Expenses Net
-1,032
-912.45
-17.323
-328.365
Income Before Tax
-15,468
-16,496
-11,946
-2,861
Income from Continuing Operations
-15,468
-16,496
-11,946
-2,861
Net Income
-15,468
-16,496
-11,946
-2,861
Net Income available to common shareholders
-15,468
-16,496
-11,946
-2,861
Basic EPS
-0.50
-0.84
-1.00
-0.27
Diluted EPS
-0.50
-0.84
-1.00
-0.27
Basic Average Shares
30,824
19,683
11,902
11,779
Diluted Average Shares
30,824
19,683
11,902
11,779